<SEC-DOCUMENT>0000904454-25-000367.txt : 20250722
<SEC-HEADER>0000904454-25-000367.hdr.sgml : 20250722
<ACCEPTANCE-DATETIME>20250722123319
ACCESSION NUMBER:		0000904454-25-000367
CONFORMED SUBMISSION TYPE:	13F-HR
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20250722
DATE AS OF CHANGE:		20250722
EFFECTIVENESS DATE:		20250722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		13F-HR
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	028-20072
		FILM NUMBER:		251139439

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		732-524-2455

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
</SEC-HEADER>
<DOCUMENT>
<TYPE>13F-HR
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xsi:schemaLocation="http://www.sec.gov/edgar/thirteenffiler eis_13F_Filer.xsd" xmlns="http://www.sec.gov/edgar/thirteenffiler" xmlns:ns1="http://www.sec.gov/edgar/common" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <schemaVersion>X0202</schemaVersion>
  <headerData>
    <submissionType>13F-HR</submissionType>
    <filerInfo>
      <liveTestFlag>LIVE</liveTestFlag>
      <flags>
        <confirmingCopyFlag>false</confirmingCopyFlag>
        <returnCopyFlag>false</returnCopyFlag>
        <overrideInternetFlag>false</overrideInternetFlag>
      </flags>
      <filer>
        <credentials>
          <cik>0000200406</cik>
          <ccc>XXXXXXXX</ccc>
        </credentials>
      </filer>
      <periodOfReport>06-30-2025</periodOfReport>
    </filerInfo>
  </headerData>
  <formData>
    <coverPage>
      <reportCalendarOrQuarter>06-30-2025</reportCalendarOrQuarter>
      <isAmendment>false</isAmendment>
      <filingManager>
        <name>JOHNSON &amp; JOHNSON</name>
        <address>
          <ns1:street1>ONE JOHNSON &amp; JOHNSON PLZ</ns1:street1>
          <ns1:city>NEW BRUNSWICK</ns1:city>
          <ns1:stateOrCountry>NJ</ns1:stateOrCountry>
          <ns1:zipCode>08933</ns1:zipCode>
        </address>
      </filingManager>
      <reportType>13F HOLDINGS REPORT</reportType>
      <form13FFileNumber>028-20072</form13FFileNumber>
      <provideInfoForInstruction5>N</provideInfoForInstruction5>
    </coverPage>
    <signatureBlock>
      <name>Marc Larkins</name>
      <title>Secretary</title>
      <phone>732-524-1476</phone>
      <signature>/s/ Marc Larkins</signature>
      <city>New Brunswick</city>
      <stateOrCountry>NJ</stateOrCountry>
      <signatureDate>07-22-2025</signatureDate>
    </signatureBlock>
    <summaryPage>
      <otherIncludedManagersCount>1</otherIncludedManagersCount>
      <tableEntryTotal>20</tableEntryTotal>
      <tableValueTotal>334096397</tableValueTotal>
      <otherManagers2Info>
        <otherManager2>
          <sequenceNumber>1</sequenceNumber>
          <otherManager>
            <cik>0000924020</cik>
            <form13FFileNumber>028-20073</form13FFileNumber>
            <name>Johnson &amp; Johnson Innovation - JJDC, Inc.</name>
          </otherManager>
        </otherManager2>
      </otherManagers2Info>
    </summaryPage>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>INFORMATION TABLE
<SEQUENCE>2
<FILENAME>infotable.xml
<TEXT>
<XML>
<?xml version="1.0" ?>
<informationTable xsi:schemaLocation="http://www.sec.gov/edgar/document/thirteenf/informationtable eis_13FDocument.xsd" xmlns="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:n1="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <infoTable>
    <nameOfIssuer>Adicet Bio, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>007002108</cusip>
    <value>228014</value>
    <shrsOrPrnAmt>
      <sshPrnamt>364472</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>364472</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Arrowhead Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>04280A100</cusip>
    <value>3981376</value>
    <shrsOrPrnAmt>
      <sshPrnamt>247598</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>247598</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>BiomX Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>09090D103</cusip>
    <value>42621</value>
    <shrsOrPrnAmt>
      <sshPrnamt>96866</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>96866</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Contineum Therapeutics Inc.</nameOfIssuer>
    <titleOfClass>CL A</titleOfClass>
    <cusip>21217B100</cusip>
    <value>8134401</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1979173</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>1979173</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>CVRx, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>126638105</cusip>
    <value>23881963</value>
    <shrsOrPrnAmt>
      <sshPrnamt>4103430</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>4103430</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Fate Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>31189P102</cusip>
    <value>3514227</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3379064</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>3379064</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Legend Biotech Corporation</nameOfIssuer>
    <titleOfClass>SPONSORED ADS</titleOfClass>
    <cusip>52490G102</cusip>
    <value>28209113</value>
    <shrsOrPrnAmt>
      <sshPrnamt>814586</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>814586</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Lyell Immunopharma Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>55083R104</cusip>
    <value>368015</value>
    <shrsOrPrnAmt>
      <sshPrnamt>41165</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>41165</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>MeiraGTx Holdings plc</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>G59665102</cusip>
    <value>43897433</value>
    <shrsOrPrnAmt>
      <sshPrnamt>6641064</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>6641064</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Nano-X Imaging Ltd.</nameOfIssuer>
    <titleOfClass>ORD SHS</titleOfClass>
    <cusip>M70700105</cusip>
    <value>830796</value>
    <shrsOrPrnAmt>
      <sshPrnamt>158852</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>158852</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Nanobiotix S.A.</nameOfIssuer>
    <titleOfClass>SPONSORED ADS</titleOfClass>
    <cusip>63009J107</cusip>
    <value>25454516</value>
    <shrsOrPrnAmt>
      <sshPrnamt>5623816</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>5623816</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Neumora Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>640979100</cusip>
    <value>1399845</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1849445</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>1849445</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Procept BioRobotics Corporation</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>74276L105</cusip>
    <value>20370308</value>
    <shrsOrPrnAmt>
      <sshPrnamt>357939</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>357939</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Protagonist Therapeutics Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>74366E102</cusip>
    <value>136395001</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2449183</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>2449183</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Rallybio Corporation</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>75120L100</cusip>
    <value>1209454</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3636363</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>3636363</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Rapport Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>75383L102</cusip>
    <value>28552723</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2498051</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>2498051</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Senseonics Holdings, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>81727U105</cusip>
    <value>26988</value>
    <shrsOrPrnAmt>
      <sshPrnamt>54621</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>54621</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Vor Biopharma, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>929033108</cusip>
    <value>1139137</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1074658</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>1074658</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Xencor, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>98401F105</cusip>
    <value>6089225</value>
    <shrsOrPrnAmt>
      <sshPrnamt>748062</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <otherManager>1</otherManager>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>748062</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Standard BioTools Inc</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>34385P108</cusip>
    <value>371241</value>
    <shrsOrPrnAmt>
      <sshPrnamt>311967</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>DFND</investmentDiscretion>
    <votingAuthority>
      <Sole>0</Sole>
      <Shared>311967</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
</informationTable>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
